NCT06566911Recruiting

Voice Analysis for Monitoring Patients With Heart Failure

Noah Labs

Start Date

1/24/2024

Completion Date

9/1/2024

Summary

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Clinically diagnosed with Acutely Decompensated Heart Failure. * At least 18 years of age. Exclusion criteria: * Disabling mental diseases (e.g., Alzheimer's disease) * Clinically diagnosed chronic obstructive pulmonary disease (COPD) * Treatment in ICU or IMU * Dialysis treatment * Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.) * Neurodegenerative diseases * Pregnancy * Inability to provide consent

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Heart Failure

Locations

Mayo Clinic

Rochester, Minnesota 55902

United States

Deutsches Herzzentrum der Charité

Berlin, 13353

Germany